Search Medical Condition
Please enter condition
Please choose location from dropdown

Levittown, Pennsylvania Clinical Trials

A listing of Levittown, Pennsylvania clinical trials actively recruiting patient volunteers.

RESULTS

Found (50) clinical trials

Study of Patients Receiving DUPIXENT for Atopic Dermatitis (AD)

This is a prospective observational study conducted to (1) characterize the patients who receive DUPIXENT for AD in a real world setting with respect to their medical history, socio-demographic and disease characteristics, and prior and concomitant treatments of AD; (2) characterize real world use patterns of DUPIXENT for AD (eg, …

Phase N/A

2.8 miles

Learn More »

Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302

The NODE-302 study is an extension of the NODE-301 efficacy study. It is a multi-centre, open label study designed to evaluate the safety of etripamil NS 70 mg when self-administered by patients for spontaneous episodes of PSVT in an outpatient setting. All patients randomized in the NODE-301 study and who …

Phase

2.8 miles

Learn More »

Observational Study of Characteristics Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)

The CHRONICLE Study is a multi-center, non-interventional, prospective cohort study of adults with severe asthma who do not achieve control with high-dose ICS therapy with additional controllers and/or require systemic corticosteroid or monoclonal antibody therapy. This study will provide a contemporary description of the epidemiology and medical management of United …

Phase N/A

2.8 miles

Learn More »

Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301

NODE-301 is a multi-centre, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a nasal spray of etripamil, a new calcium channel blocker, in patients who experience an episode of paroxysmal ventricular tachycardia (PSVT). The study will comprise of 2 parts, Part 1 and Part 2. Part 1 …

Phase

2.8 miles

Learn More »

Multiple Cardiac Sensors for the Management of Heart Failure

Phase I of the MANAGE-HF trial is not randomized, and is intended to evaluate the clinical integration of HeartLogic for managing patients with heart failure. There are no endpoints. Phase II of the MANAGE-HF trial will assess the clinical effectiveness of remote monitoring of heart failure patients with implanted CRT-D …

Phase N/A

2.8 miles

Learn More »

Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)

The study is conducted to improve knowledge about the epidemiology of Lipoprotein(a) in patients with established cardiovascular disease (CVD).

Phase N/A

2.8 miles

Learn More »

The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol

Acne vulgaris is a common skin problem which can be challenging to treat. Enhancing the efficacy and tolerability of treatment regimens can enhance compliance and outcomes thereby potentially decreasing the morbidities associated with acne vulgaris. The present study is designed to assess the ability of Power of 3 with resveratrol …

Phase

2.8 miles

Learn More »

Benefits of Cor in Ambulatory Decompensated Heart Failure

Subjects meeting the inclusion/exclusion criteria will wear Cor for 90 days from the day of fitting. 500 total patients will be enrolled. There will be an interim analysis when the 200th subject has finished the study in the study to assess for distribution of patients with reduced and preserved LVEF. …

Phase N/A

2.8 miles

Learn More »

A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease

This study will evaluate Advanced Laboratory Services Borrelia diagnostic test by culturing Borrelia spirochetes from human serum in subjects with early or late Lyme disease. This is an 8 month study. Subjects entering the study will have two blood samples collected one month apart if they have early Lyme disease …

Phase N/A

3.34 miles

Learn More »

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

This is a blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with increased risk for cardiovascular (CV) disease.

Phase

3.34 miles

Learn More »